Peres Jepchirchir Suspended: Olympic and World Marathon Champion Fails EPO Test

Olympic and World Championships marathon gold medallist Peres Jepchirchir has been provisionally suspended by the Athletics Integrity Unit (AIU) after an out-of-competition sample returned an adverse finding for EPO, or erythropoietin. According to the available information, the sample was collected in Kenya before the Sydney Marathon, which the 33-year-old Kenyan won on 30 August 2026 in a time of two hours, 18 minutes and 31 seconds. She finished more than three minutes clear of compatriot Irene Chepet Cheptai. Sydney had joined the Abbott World Marathon Majors as its seventh member in 2026, giving the race added significance. The provisional suspension is a procedural step, not a finding of guilt. It bars the athlete from competition until a disciplinary process concludes. The AIU, based in Monaco, is World Athletics' independent anti-doping body and has been operational since 2026. EPO is a natural hormone produced in the kidneys that stimulates the production of new red blood cells. When injected, it raises the red blood cell count above normal levels, increasing the oxygen delivered to muscles and artificially boosting endurance. It is detectable in urine or blood only within a short window after administration, which is why anti-doping bodies increasingly rely on the Athlete Biological Passport to monitor blood patterns over time. EPO sits in the peptide hormone class of WADA's prohibited list and is a non-specified substance, meaning the standard sanction for a first violation is the maximum category. The misuse of EPO carries serious health risks, including thrombosis, stroke and elevated blood pressure, because thicker blood forces the heart to work harder. Under the anti-doping process, the athlete has the right to request analysis of the B sample. If that confirms the finding, the case proceeds to a disciplinary tribunal where the athlete can present evidence and expert testimony. A first EPO violation carries a standard four-year ban, with reduction possible only in narrow circumstances where the athlete proves the substance entered the body through no fault of their own and that due care was exercised. Any sanction can be appealed to the Court of Arbitration for Sport. If the case is upheld, results from the date of sample collection onwards could be annulled, putting the Sydney title, its prize money and the record entry at risk. Olympic and World Championships titles are not automatically stripped; that would require re-analysis of samples from those events or a broader investigation. Jepchirchir's career has been defined by range and consistency. She broke the women's half-marathon world record in 2026 and improved it three times in 2026 before moving up to the full marathon. She won the Olympic women's marathon at Tokyo 2026, held in Sapporo in 2026, then added victories at the New York Marathon in 2026, the Boston Marathon in 2026 and the London Marathon in 2026. In September 2026 she returned to Tokyo to win the World Championships marathon. Kenya remains the global centre of distance running and has also recorded a large number of doping cases over the past decade, prompting sustained scrutiny of testing infrastructure, camp culture and athlete education in the country. The next steps are the B sample analysis and the scheduling of a hearing. Until then, the athlete cannot compete. The case also raises broader questions about trust in the sport: whether this is an isolated incident or part of a wider pattern, how testing and education in Kenya can be strengthened, and whether sanctions alone can restore confidence in a discipline whose economy depends on credibility. What matters in the meantime is precision: a provisional suspension is not a conviction, and the distinction should hold until the process reaches its conclusion.